Intestinal SGLT1-mediated absorption and metabolism of benzyl β-glucoside contained in Prunus mume:: carrier-mediated transport increases intestinal availability

被引:4
|
作者
Mizuma, T [1 ]
Nakamura, M [1 ]
Ina, H [1 ]
Miyazaki, T [1 ]
Hayashi, M [1 ]
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Drug Absorpt & Pharmacokinet, Tokyo 1920392, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2005年 / 1722卷 / 02期
基金
日本学术振兴会;
关键词
benzyl glucoside; intestinal absorption; intestinal availability; SGLT1; Prunus mume;
D O I
10.1016/j.bbagen.2004.12.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The intestinal absorption of benzyl beta-glucoside (BNZ beta glc) contained in the fruit of Prunus mume SIEB. et ZUCC. (Rosaceae), which is traditionally used as a medicinal food in Japan, was studied in rat intestines. BNZ beta glc was absorbed from the mucosal to serosal sides. Its metabolite, benzyl alcohol (BAL), was also detected on both the mucosal and serosal sides. In the presence of phloridzin (Na+/glucose cotransporter (SGLT1) inhibitor) or in the absence of Na+ (driving force), BNZ beta glc absorption was significantly decreased. Transport clearance of BNZ beta glc across the brush border membrane decreased as its concentration increased. These results indicate that BNZ beta glc is transported by SGLT1. Metabolic clearance of BNZ beta glc also decreased as its concentration increased. The amount ratio of BNZ beta glc to BAL on the serosal side increased with the increase of BNZ beta glc concentration. The intestinal availability of BNZ beta glc was lower in the absence of Na+ than in the presence of Na+, indicating that the SGLT1-mediated transport of BNZ beta glc increases intestinal availability by decreasing the intestinal extraction ratio. This neutraceutical study concluded that intestinal carrier-mediated transport across the brush border membrane improves the intestinal availability of nutritionally, pharmacologically or physiologically active compounds that undergo intestinal metabolism (first-pass effect). (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 7 条
  • [1] SGLT1-mediated transport of glucoside increase intestinal availability
    Nakajima, Y
    Nakamura, M
    Mizuma, T
    Ina, H
    Miyazaki, T
    Hayashi, M
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2004, 124 : 97 - 100
  • [2] Carrier-mediated intestinal transport of drugs
    Tsuji, A
    Tamai, I
    PHARMACEUTICAL RESEARCH, 1996, 13 (07) : 963 - 977
  • [3] Molecular characterization of intestinal absorption of drugs by carrier-mediated transport mechanisms
    Tamai, I
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1997, 117 (07): : 415 - 434
  • [4] EFFECT OF CARRIER-MEDIATED TRANSPORT-SYSTEM ON INTESTINAL FOSFOMYCIN ABSORPTION INSITU AND INVIVO
    ISHIZAWA, T
    HAYASHI, M
    AWAZU, S
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1991, 14 (02): : 82 - 86
  • [5] LINOLENIC ACID TRANSPORT IN HAMSTER INTESTINAL-CELLS IS CARRIER-MEDIATED
    GORE, J
    HOINARD, C
    JOURNAL OF NUTRITION, 1993, 123 (01): : 66 - 73
  • [6] In situ and in vitro evidence for stereoselective and carrier-mediated transport of monocarboxylic acids across intestinal epithelial tissue
    Ogihara, T
    Tamai, I
    Tsuji, A
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2000, 23 (07) : 855 - 859
  • [7] Enhancement of intestinal transport of thyrotropin-releasing hormone via a carrier-mediated transport system by chemical modification with lauric acid
    Tanaka, K
    Fujita, T
    Yamamoto, Y
    Murakami, M
    Yamamoto, A
    Muranishi, S
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1996, 1283 (01): : 119 - 126